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Objective. Depression has been associated with increased cardiovascular disease risk, and a depression-related elevation of high
sensitivity C-reactive protein (hs-CRP) has been proposed as a possible mechanism. The objective of this paper is to examine
association between depression and high sensitivity C-reactive protein (hs-CRP). Methods. Subjects consisted of 508 healthy
adults (mean age 48.5 years; 49% women, 88% white) residing in central Massachusetts. Data were collected at baseline and at
quarterly intervals over a one-year period per individual. Multivariable linear mixed models were used to assess the association
for the entire sample and by gender. Results. The mean Beck Depression Inventory score was 5.8 (standard deviation (SD) 5.4;
median 4.3), and average serum hs-CRP was 1.8mg/L (SD 1.7; median 1.2). Results from the multivariable linear mixed models
show that individuals with higher depression scores have higher levels of hs-CRP. Analyses by gender show persistence of an
independent association among women, but not among men. Body mass index (BMI = weight(kg)/height(m)2) appears to be a
partial mediator of this relationship. Conclusion. Depression score was correlated to hs-CRP levels in women. Further studies are
required to elucidate the biological mechanisms underlying these associations and their implications.
1. Introduction
Depression and inflammatory biomarkers have both been
proposed as novel coronary heart disease (CHD) risk
markers [1, 2]. Depression and CHD are common conditions
that often occur together. Evidence suggests that their
cooccurrence is not random, but is driven by depression
as a risk factor for the occurrence and progression of
CHD [3]. This link is thought to be due, in part, to the
impact that depression has on neuroendocrine pathways
that influence the pathogenesis and progression of coronary
atherosclerosis and subsequent heart disease [4]. These
include inflammatory markers, particularly high-sensitivity
C-reactive protein (hs-CRP) [5]. Some studies suggest that
the existence of a possible “psychoneuroimmune link”
between negative aﬀectivity (depression, anger and anxiety
[6], poor subjective wellbeing [7]), inflammatory markers,
and the development and progression of CHD [2]. Several
behavioral and psychosocial factors, particularly depression,
appear to increase the risk for acute coronary syndrome
events independent of traditional risk factor status [8].
Ameta-analysis of 11 cohort studies suggests that depression,
assessed by self-reported symptoms or by formal psychiatric
evaluation, significantly predicts risk for first CHD events
independent of established CHD risk factors [1]. Similarly,
elevated inflammatory biomarkers, hs-CRP in particular,
have been established as risk markers for incident CHD
events [2], and there are reports describing the under-
lying cellular and molecular mechanisms by which these
biomarkers facilitate the development of atherosclerosis [9].
Although depression and hs-CRP are both associated with
CHD events, less is known about their possible association
with each other [1, 5, 10]. A review of NHANES III data
indicated that a history of major depression was associated
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with a 64% increase in the risk of having an elevated hs-CRP
level. However, the association between depression and hs-
CRP was much stronger among men than among women
[10], an observation also reported in Europe [11] and Israel
[12].
The goal of the present study was to analyze the rela-
tionship between hs-CRP and depression scores in healthy
adults using longitudinal analysis, and to examine potential
gender diﬀerences. This is important because, as pointed out
by Shimbo and colleagues [5], cross-sectional data cannot
determine the temporal nature of the relationship. We
utilized available data from the Seasonal Variation in Blood
cholesterol levels (SEASONS) study, which was designed to
describe and prospectively delineate the nature and causes
of seasonal variation in blood lipids, and is described in
detail elsewhere [13, 14]. The SEASONS database provides
a unique opportunity to examine the relationship of depres-
sion and hs-CRP in healthy adults by gender over a one-
year time period, while controlling for a variety of socio-
economic, anthropometric, physiologic, dietary, physical
activity, and psychosocial factors.
2. Methods
2.1. Subject Recruitment and Study Design. The SEASONS
study population consisted of 641 healthy adults, aged 20 to
70 years, enrolled at the Fallon Healthcare System, a health
maintenance organization in central Massachusetts [13]. Eli-
gible subjects, (1) were not taking cholesterol-lowering med-
ications; (2) were not following a lipid-lowering or weight-
control diet; (3) were not working night shifts; (4) were
free from possible causes of secondary hypercholesterolemia
(e.g., hypothyroidism, pregnancy); (5) did not have a chronic
life-threatening illness (e.g., cancer, renal disease, or heart
failure), and did not have evidence of clinical atherosclerotic
disease such as coronary disease, stroke, or peripheral
vascular disease. Subjects were followed prospectively for
one year, during which time quarterly measurements were
made of their serum lipids, hs-CRP, diet, physical activity,
anthropometric measures, light exposure, and psychosocial
factors. Subjects were recruited between December 1994
and February 1997 and enrollment occurred throughout the
calendar year. The Institutional Review Boards of the Fallon
Healthcare System and the University of Massachusetts
Medical School approved all subject recruitment and data
collection procedures.
2.2. Blood Sample Collection and Hs-CRP Assays. During
each visit, a 12-hour-fasting blood sample was collected
between 7 and 10 am. Serum was isolated and refrigerated
at −70◦C. Samples were transported to Dr. Nader Rifai’s
laboratory, in Boston, MA, and hs-CRP was measured using
latex-enhanced immunonephelometric assays on a BN II
analyzer described previously [15]. The measurement of hs-
CRP was performed in batches. Inter-assay and intra-assay
coeﬃcients of variation for hs-CRP were in compliance with
CDC-accepted ranges. In addition, we excluded 66 (3% of
total) CRP values greater than 10mg/L from this analysis
because such elevated values are likely to be caused by acute
infection or underlying medication problems [16].
2.3. Beck Depression Inventory. Depression symptoms were
assessed using the Beck Depression Inventory (BDI) [17].
The BDI is a questionnaire developed to measure the
intensity, severity, and depth of depressive symptoms. It
is composed of 21 questions, each designed to assess a
specific symptom common among people with depres-
sion. BDI items assess mood, pessimism, sense of fail-
ure, self-dissatisfaction, guilt, punishment, self-dislike, self-
accusation, suicidal ideas, crying, irritability, social with-
drawal, body image, work diﬃculties, insomnia, fatigue,
appetite, weight loss, bodily preoccupation, and loss of
libido. Items 1 to 13 assess symptoms that are psychological
in nature, while items 14 to 21 assess more physical
symptoms [17]. Each of 21 questions or items has four
possible responses. Each response is assigned a score ranging
from zero to three, indicating the severity of the symptom
and the overall score is calculated from the sum of responses
to each item. A cut-oﬀ score of 21 or higher represents
clinically-significant depressive symptomatology. The BDI
was self-administered at baseline (upon study enrollment)
and every 3 months thereafter for 12 months, for a total of
fivemeasurement points over one year of study participation.
2.4. Assessment of Diet and Physical Activity. Serial 24-hour
dietary recall interviews (24HDR), three in each quarter
of followup, were performed on randomly selected days
(two weekdays and one weekend day) by trained registered
dieticians in order to quantify dietary changes over the week.
The 24HDR data were collected using the nutrition data
System (NDS) data entry and nutrient database software
developed and maintained by the Nutrition Coordinating
Center at the University of Minnesota, Minneapolis [18].
Data collection for physical activity patterns also occurred
at the time of the 24HDR. Subjects were asked to recall
the amount of time they spent in light, moderate, vigorous,
and very vigorous activities in household, occupational,
and leisure-time activity domains. Estimates of physical
activity energy expenditure in metabolic equivalent task
hours (MET-hours) were calculated according to methods
developed by Ainsworth and colleagues [19]. These data were
validated against both accelerometers and standard ques-
tionnaires. Results obtained were comparable to published
data from other short-term activity assessments employing
the Beck Questionnaire and activity monitors as criterion
measures [20].
2.5. Demographic, Anthropometric, and Blood Lipid Data.
Detailed demographic, anthropometric, and blood lipid
data collection methods are described elsewhere in our
previous publications [13, 21, 22]. Briefly, demographic data
including gender, age, race/ethnicity, educational level, occu-
pational category, and so forth, were collected by a self-report
questionnaire at baseline. Self-reported smoking status was
ascertained at baseline and again at each quarter of followup
by additional self-administered questionnaires. Height was
measured at baseline, and body weight was measured at
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each clinic visit, with the subject removing their shoes and
extra layers of clothing. Relative mass was expressed as BMI
(weight (kg)/height (m)2). Subjects were classified as “over-
weight” if their BMI was equal or greater than 25 kg/m2 and
as “obese” if their BMI was equal or greater than 30 kg/m2.
Fasting (>12 hours) venous blood samples (10mls) were
obtained after sitting for 15 minutes at each clinic visit.
Blood plasma was harvested by low-speed centrifugation at
4◦C, aliquoted into individual tubes, and quickly frozen to
−70◦C. On a regular basis, plasma samples were packed in
dry ice and shipped for analysis via overnight service to
the Centers for Disease Control standardized laboratory at
the University of Massachusetts at Lowell [23]. Assays for
total cholesterol, HDL-C and triglycerides were done in this
laboratory. LDL-C was calculated by the Friedewald formula
(LDL-C = total cholesterol − {triglycerides/5 + HDL-C})
[24]. When triglycerides exceeded 400mg/dl, the LDL-C was
not calculated.
2.6. Statistical Analyses. Gender diﬀerences in demographic
characteristics were assessed using two-group t-tests for
continuous variables and Chi-square tests for categorical
variables. Linear mixed models with a random intercept
for each subject and unstructured within-subject correlation
were used to assess the association between depression
scores and hs-CRP levels. With this model, we examined
both (1) the cross-sectional association (between-subject,
i.e., the subject-specific average) between depression and hs-
CRP and (2) the longitudinal association (within-subject,
i.e., quarterly diﬀerences from the subject-specific average)
between depression and hs-CRP. This method has been used
in our previous analyses of the association between dietary
carbohydrates and body weight and blood lipids, and the
association between dietary fiber and hs-CRP [15, 21, 22].
The models were also adjusted for variables known to
aﬀect hs-CRP (e.g., BMI, smoking, and infection) and were
repeated using either the raw values or logarithmic scales of
both hs-CRP and Beck depression scores. Dietary and phys-
ical activity variables were considered in the multivariable
linear mixed models, but they were not significantly related
to hs-CRP when multiple variables were considered, and so
they were not included in the final models. Gender-specific
mixed model analyses were also conducted. All analyses were
performed using Stata SE 9.2 (College Station, Texas).
3. Results
Of the 641 participants in the SEASONS study, 508 (79%)
had at least two visits yielding both BDI score and hs-CRP
values, and data derived from these individuals were included
in the analyses. Of these 508 subjects, over 55% had paired
BDI and hs-CRP data for 4 or more data points throughout
the year, and 30% had all 5 measures.
Study participants were primarily middle-aged, white,
well-educated, employed, nonsmoking, and generally over-
weight or obese (Table 1), and approximately half (49%)
were women. Compared to women, men were more likely
to be married or living with a partner, to have had a college
education, to be employed full-time, and to be either
overweight or obese (72% versus 53% for men and women,
resp.). Men also reported significantly higher levels of caloric
intake and physical activity as compared to women. Blood
pressure was higher, and resting- heart rate was lower among
men. Compared to men, women had significantly lower
levels of triglycerides, higher levels of HDL-cholesterol, and
a higher prevalence of minor inflammatory or infectious
problems (Table 1).
Mean BDI score was 5.8 (standard deviation (SD) 5.4);
median 4.3; range from 0 to 33 with only 2% of partic-
ipants presenting scores above 21, suggestive of clinically
significant depressive symptoms (1.2% of men and 2.8%
of women, P = .10). Only 13 participants reported tak-
ing antidepressant medication, with 10 reporting taking
antidepressants throughout the year. The limited number
of participants taking antidepressant drugs precludes any
meaningful subgroup-analyses for this characteristic. There
were significant gender diﬀerences in average BDI scores: 5.2
(SD 4.8; median 4.0) among men and 6.5 (SD 6.0; median
4.6) among women, P < .005. Overall average serum hs-
CRP was 1.8mg/L (SD 1.7; median 1.2), with no statistically
significant gender diﬀerences. Using the average values of five
hs-CRP and depression measures from each individual, BDI
scores and hs-CRP were positively correlated as depicted in
Figure 1.
Results from the multivariable linear mixed models,
controlling for age, BMI, resting heart rate, HDL-cholesterol,
smoking status, and reports of minor infection or inflamma-
tion, suggest that individuals with higher depression scores
tended to have higher hs-CRP levels (β = 0.03, P < .05)
however, we failed to observe a significant longitudinal eﬀect
(Table 2). Analyses stratified by gender suggest that an inde-
pendent association between depression score and hs-CRP is
present among women (β = 0.028, P < .05), but not among
men (β = 0.024, P > .05). Overall, other factors significantly
and positively related to hs-CRP included BMI, age, resting-
heart rate, and report of minor infection/inflammation
process. Repeating multivariable analyses using log trans-
formation for hs-CRP and BDI score, independently and
together, showed similar results to that of the analyses using
raw values (data not shown). However, they also suggested
an inverse longitudinal relationship between BDI score and
hs-CRP among women, that is, women, whose BDI score
increased over the year showed a decline in levels of hs-CRP,
and this was not related to weight loss.
4. Discussion
Findings from this longitudinal study are consistent with
the results of prior cross-sectional studies suggesting that
depression is cross-sectionally associated with higher hs-CRP
levels in a population without evidence of a chronic life-
threatening illness (e.g., cancer, or renal or heart failure).
Among our sample of adults not reporting clinically signifi-
cant depressive symptomatology, depression score appears to
be independently and positively correlated to hs-CRP. After
controlling for potentially confounding factors, analysis by
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Table 1: Characteristics of study participants, overall and by gender, SEASONS study, Worcester, MA, 1994–1998.
Variables
Overall (n = 508) Men (n = 259) Women (n = 249) P value for gender
comparisonN (%)/Mean N (%)/Mean N (%)/Mean
Age (years) 48.5 49.1 47.9 .28
Race
White 436 (87.6%) 228 (87.2%) 208 (85.6%) .19
Marital Status
Married or Living with Partner 392 (77.3%) 214 (83.0%) 178 (71.5%) .19
Education <.001
Less than high school 125 (24.7%) 42 (16.3%) 83 (33.5%)
Some college or Associates degree 181 (35.8%) 106 (41.1%) 75 (30.2%)
College/graduate or more 200 (39.5%) 110 (42.6%) 90 (36.3%)
Employment .001
Full-time 336 (66.1%) 191 (73.8%) 145 (58.2%)
Part-time 76 (15.0%) 27 (10.4%) 49 (19.7%)
Unemployed/retired 96 (18.9%) 41 (15.8%) 55 (22.1%)
Current smoking
Yes 71 (15.0%) 35 (15.0%) 36 (15.1) .97
Body Mass Index (BMI) classification <.001
Normal (18.5–24.9 kg/m2) 188 (37.0%) 72 (27.8%) 116 (46.6%)
Overweight (25–29.9 kg/m2) 206 (40.6%) 121 (46.7%) 85 (34.1%)
Obese (≥30 kg/m2) 114 (22.4%) 66 (25.5%) 48 (19.3%)
Mean BMI (kg/m2) 27.2 27.8 26.6 .01
Blood Measurements
High Sensitivity C-Reactive Protein
mg/L (from natural log
distribution)
1.05 1.09 1.01 .37
Total cholesterol (mg/dl)∗ 219.6 221.5 217.6 .28
LDL (mg/dl)∗ 143.6 146.2 140.8 .08
HDL (mg/dl)∗ 48.1 43.3 53.0 <.0001
Triglycerides (mg/dl)∗∗ (from
natural log distribution)
118.8 136.4 102.8 <.0001
Dietary factors
Total caloric intake (kcal per day) 1957 2263 1640 <.0001
% of calories from total fat 31.4 32.1 30.7 <.01
% of calories from saturated fat 11.2 11.5 10.9 .02
Total fiber intake (gram per day) 16.2 18.0 14.3 <.0001
Physical activity
Total MET-h/d 30.17 31.58 28.71 <.0001
Leisure MET-h/d 1.87 2.07 1.67 .03
Occupational MET-h/d 4.32 5.74 2.85 <.0001
Household MET-h/d 4.8 4.6 5.0 .13
Psychosocial factors
Beck Depression Inventory Score
(from natural log distribution)
3.4 3.0 3.8 .11
Prevalence of depression (% with
BDI scores ≥21) 10 (2.0%) 3 (1.2%) 7 (2.8%) .18
Antidepressant Medication Use 11 (2.2%) 4 (1.5%) 7 (2.8%) .3
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Table 1: Continued.
Variables
Overall (n = 508) Men (n = 259) Women (n = 249) P value for gender
comparisonN (%)/Mean N (%)/Mean N (%)/Mean
Physiologic measures and other
Systolic blood pressure—mmHg 119 124 113 <.0001
Diastolic blood pressure—mmHg 75 77 73 <.0001
Heart rate—beats/min 69.7 67.1 72.3 <.0001
Prevalence of infection
inflammation %
56 (30.0%) 19 (20.2%) 37 (39.8%) .003
∗
To transform total cholesterol, LDL, and HDL units from mg/dL to mmol/L multiply value by 0.0259.
∗∗To transform triglyceride units from mg/dL to mmol/L multiply value by 0.0113.
Due to missing values the total number of subjects diﬀers.
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Figure 1: Association between Beck Depression Inventory score and high sensitivity C-reactive protein in men (a) and in women (b),
SEASONS Study, Worcester MA, 1994–1998.
gender revealed that this association persisted only among
women. The disappearance of this relationship among men
after controlling for potential confounders, suggests that
factors such as BMI, age, and resting heart rate (a marker of
physical fitness) may confound this association among men.
These factors also appear to mediate the relationship among
women, but to a lesser extent.
Previous studies suggest that some types of depression
are associated with weight gain which in turnmay exacerbate
inflammation by inducing leptin expression and increasing
synthesis of inflammatory cytokines by adipose tissue [25].
Thus, the relationship between depression and hs-CRP
may, at least partially, be mediated by weight gain. While
our participants were, on average, not in the clinically
depressed range, our findings suggest that the range of
depressive symptomatology may be important, with low
levels of depressive symptomatology having significance in
these associations. The proposition that elevated depressive
symptomatology leads to weight gain, and increase in body
weight leads in turn to an increase in hs-CRP, would be a
plausible explanation for our observation of the attenuation
of the relationship between depression and inflammation
among women, and the disappearance of the eﬀect among
men, after controlling for BMI.
The “psychoneuroimmune link” theory as an explana-
tion of the relationship between the range of depressive
symptomatology and hs-CRP can not be confirmed from the
observations in this study; however, our findings support an
independent association between depression scores and hs-
CRP observed in women. On the other hand, among women,
the observation of an independent and inverse relationship
between depression scores and hs-CRP, over time, suggests
that the relationship is complex and might be mediated
mostly by behavior, since depression is related to changes in
appetite and body weight, in either direction.
Our results are in contrast with reports from the
NHANES III survey [10], which found that the relationship
between hs-CRP and depression is stronger among men than
in women. However, those reports used major depression
diagnosis in contrast to depressive symptom scores as
used in this analysis. The association between hs-CRP and
depression was not observed in a recent study from adoles-
cents aged 13–16 years old [26]. Diﬀerences in population
characteristics and in the confounders controlled, also could
account for some of the inconsistent results.
There are several strengths to our investigation. First,
we collected detailed longitudinal data on a quarterly basis
over the course of one year in various domains, including
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Table 2: Multivariable Linear Mixed Model Predicting High Sensitivity C-Reactive Protein, SEASONS Study. Worcester MA, 1994–1998.
Overall Coeﬃcient Standard Error 95% CI lower limit 95% CI upper limit
Beck Depression Inventory score—average 0.030 0.011 0.009 0.051
Beck Depression Inventory score—residual −0.006 0.011 −0.027 0.016
Age in years 0.018 0.005 0.008 0.027
Body Mass Index kg/m2—average 0.162 0.012 0.139 0.186
Body Mass Index kg/m2—residual 0.111 0.051 0.012 0.211
Heart Rate beats per minute—average 0.017 0.006 0.006 0.029
Heart Rate beats per minute—residual 0.014 0.004 0.005 0.023
HDL Cholesterol mg/dl—average −0.003 0.005 −0.013 0.007
HDL Cholesterol mg/dl—residual −0.010 0.007 −0.023 0.003
Smoking 0.269 0.143 −0.012 0.549
Minor infection-inflammation 0.280 0.069 0.145 0.414
Constant −4.894 0.646 −6.160 -3.628
Men
Beck Depression Inventory score—average 0.024 0.017 −0.009 0.058
Beck Depression Inventory score—residual 0.003 0.016 −0.029 0.034
Age in years 0.026 0.006 0.013 0.038
Body Mass Index kg/m2—average 0.122 0.020 0.082 0.161
Body Mass Index kg/m2—residual −0.059 0.078 −0.211 0.093
Heart Rate beats per minute—average 0.011 0.008 −0.006 0.027
Heart Rate beats per minute—residual 0.013 0.007 0.000 0.026
HDL Cholesterol mg/dl—average −0.005 0.008 −0.022 0.012
HDL Cholesterol mg/dl—residual −0.020 0.010 −0.040 0.000
Smoking 0.174 0.188 −0.194 0.542
Minor infection—inflammation 0.375 0.097 0.185 0.565
Constant −3.699 1.008 −5.675 1.724
Women
Beck Depression Inventory score—average 0.028 0.014 0.001 0.055
Beck Depression Inventory score—residual −0.019 0.014 −0.046 0.008
Age in years 0.011 0.007 −0.003 0.025
Body Mass Index kg/m2—average 0.184 0.015 0.156 0.213
Body Mass Index kg/m2—residual 0.222 0.063 0.099 0.345
Heart Rate beats per minute—average 0.023 0.009 0.005 0.041
Heart Rate beats per minute—residual 0.020 0.006 0.009 0.031
HDL Cholesterol mg/dl—average −0.006 0.007 −0.019 0.008
HDL Cholesterol mg/dl—residual −0.007 0.008 −0.023 0.009
Smoking 0.370 0.216 −0.053 0.794
Minor infection—inflammation 0.172 0.092 −0.008 0.352
Constant −5.323 0.954 −7.192 −3.453
demographic, psychosocial, dietary, and physical activity.
Second, our study controlled for potential confounding
factors for the depression and hs-CRP relationship, which
previous studies had not included. Third, the study popu-
lation is relatively healthy; subjects with diabetes and other
chronic diseases were excluded as these conditions have
been associated with both depressive symptoms and hs-
CRP levels and may thus confound the BDI and hs-CRP
relationship. Fourth, our data came from a study of seasonal
variation in blood lipids, therefore patients planning to use
or are using lipid medications and hormone therapy were
excluded. Consequently, any eﬀect of using statins and female
hormones on hs-CRP concentrationswas eliminated. Finally,
use of a continuous measure of depressive symptomatology
(BDI scores) allowed analyses across the continuum of
depressive symptom severity.
Our study also has potential limitations. The study
sample had a reduced range of depression scores, which
limits our capacity to draw conclusions for individuals in the
clinical-depression range. Although, the finding of a positive
association between depressive symptom score and hs-CRP
among adults who were on average not clinically depressed
is also of interest, because it suggests that the entire range
of depressive-symptomatology may be associated with health
Cardiology Research and Practice 7
risks. On the other hand, participants in this study were
predominantly white, well-educated and employed therefore,
caution should be taken when generalizing to populations
that have diﬀerent demographic characteristics or depression
scores diﬀering from the range found in this study. Finally, as
with many studies that require a strong commitment on the
part of the participants, selection bias is always possible.
In conclusion, multivariable longitudinal analyses sug-
gest that an independent association between depression
scores and hs-CRP is present among women, but not among
men. It appears that obesity partially mediates this rela-
tionship. Other factors that were significantly and positively
related to hs-CRP included body mass index, age, resting-
heart rate, and concurrent minor infection/inflammation
process. Further studies are required to elucidate the biolog-
ical mechanisms of these associations and their implications.
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